From August 10, 2022 to October 1, 2022, the company has repurchased 786,164 shares, representing 1.53% for $59.12 million. With this, the company has completed the repurchase of 786,164 shares, representing 1.53% for $59.12 million under the buyback announced on August 10, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
85.34 USD | -1.02% | +2.35% | -0.11% |
Apr. 04 | Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge | MT |
Apr. 04 | Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.11% | 4.38B | |
-3.30% | 185B | |
-4.18% | 107B | |
-5.11% | 67.55B | |
+8.97% | 54.6B | |
+16.11% | 47.42B | |
+3.86% | 42.24B | |
+8.28% | 28.24B | |
-0.37% | 26.42B | |
+12.40% | 25.66B |
- Stock Market
- Equities
- HAE Stock
- News Haemonetics Corporation
- Tranche Update on Haemonetics Corporation's Equity Buyback Plan announced on August 10, 2022.